SCIENTISTS PROVE: STRANDJAN MAN HONEY DESTROYS CANCER CELLS
After 3 years of research Prof. Dr. Collay from Karadeniz Technical University said: "Oak manna honey is rich in phenolic acids and has 5 times more antioxidant character than nectar honey."
Analytical studies conducted at Karadeniz Technical University report that samples of oak honey taken from different parts of the Strandzha Mountains in the towns of Kirklareli and Demirkoy near Bulgaria have higher antioxidant activity than other honeys.
The most important factors for the high antioxidant activity of oak honey is the presence of a high degree of QUARTZETIN, GALIC ACID, CAFFEIC ACID FENETHYL ESTER, R-CUMARINIC ACID, ELAGIC ACID. They prevent many diseases such as diabetes, heart disease and lung disease, as well as stop or prevent reactions caused by free radicals that cause cancer.
In another study, the head of the department of medical biochemistry, Prof. Dr. Abdurrahim Kotsyugit, revealed the ability of manna honey to kill cancer cells.
In 2018, a 9-member team of scientists studied 14 samples of different types of honey, chestnut, pine, cedar, oak and nectar honey.
As a result of research, it was found that honey, which is the richest in phenolic content and has the highest potential for killing cancer cells, is manna honey, which is obtained from acorn juice.
Prof. Dr. Kotsyugit said: "The ideal method of killing cancer cells in the treatment of stomach cancer is controlled cell death, called apoptosis. In apoptosis, these cells are absorbed by macrophages and destroyed in a controlled manner. Therefore, they do not harm the body, unlike chemotherapy.
Honey, whose preclinical stages have been completed and whose clinical trials are ongoing, is intended to be used both to prevent the appearance of cancer cells and to treat already existing cancer cells.
"If you want to prevent cancer, you need to take a low dose of manna honey. In those who have cancer, low doses increase cancer cells and high doses kill cells. At the moment we cannot say which dose is low and which is high. Only after experimental animal and clinical studies on humans will we be able to say this. Research is ongoing. "